TrianglePUBLICATIONS · 32179448
Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Eur J Cancer
- Publication date
- 2020 May
- First author
- Ferrari A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Ferrari A
- type
- Author
- name
- Merks JHM
- type
- Author
- name
- Chisholm JC
- type
- Author
- name
- Orbach D
- type
- Author
- name
- Brennan B
- type
- Author
- name
- Gallego S
- type
- Author
- name
- van Noesel MM
- type
- Author
- name
- McHugh K
- type
- Author
- name
- van Rijn RR
- type
- Author
- name
- Gaze MN
- type
- Author
- name
- Martelli H
- type
- Author
- name
- Bergeron C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ferrari A
- type
- Author
- name
- Merks JHM
- type
- Author
- name
- Chisholm JC
- type
- Author
- name
- Orbach D
- type
- Author
- name
- Brennan B
- type
- Author
- name
- Gallego S
- type
- Author
- name
- van Noesel MM
- type
- Author
- name
- McHugh K
- type
- Author
- name
- van Rijn RR
- type
- Author
- name
- Gaze MN
- type
- Author
- name
- Martelli H
- type
- Author
- name
- Bergeron C
- type
- Author
- bibliography ids
- nci-bib-9620da293eb6f5dc02b16922
- book metadata
- content sha256
- 18b54f4526e038a3131e19d08903d2ed461c65cacaeaf3fd2657dbfc6438a986
- document type
- citation
- dois
- 10.1016/j.ejca.2020.01.029
- electronic publication date
- display
- 2020 Mar 13
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32179448
- immutable id
- pubmed:32179448@18b54f4526e038a3131e19d08903d2ed461c65cacaeaf3fd2657dbfc6438a986
- journal
- abbreviation
- Eur J Cancer
- issn electronic
- 1879-0852
- issn print
- 0959-8049
- issue
- Source null
- name
- European journal of cancer (Oxford, England : 1990)
- nlm unique id
- 9005373
- pages
- 72-80
- volume
- 130
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 32179448
- provenance
- batch id
- 4c5003fbb78890e89ae1
- provider
- NCBI PubMed ESummary
- record sha256
- 29be3d66ce3d457a369231fe6673e199d53a85e6f9f8abc6de54b73cf97bbf0d
- response sha256
- 890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
- retrieved at
- 2026-09-09T23:47:48.270700+00:00
- publication date
- display
- 2020 May
- precision
- month
- year
- 2020
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy.
Preserved source evidence · Not medical advice